Cargando…
Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070243/ https://www.ncbi.nlm.nih.gov/pubmed/27843629 http://dx.doi.org/10.1136/esmoopen-2016-000079 |
| _version_ | 1782461105076961280 |
|---|---|
| author | Sartore-Bianchi, Andrea Valtorta, Emanuele Amatu, Alessio Veronese, Silvio Lauricella, Calogero Bonazzina, Erica Siravegna, Giulia Truini, Mauro Bardelli, Alberto Siena, Salvatore |
| author_facet | Sartore-Bianchi, Andrea Valtorta, Emanuele Amatu, Alessio Veronese, Silvio Lauricella, Calogero Bonazzina, Erica Siravegna, Giulia Truini, Mauro Bardelli, Alberto Siena, Salvatore |
| author_sort | Sartore-Bianchi, Andrea |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5070243 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50702432016-11-14 Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer Sartore-Bianchi, Andrea Valtorta, Emanuele Amatu, Alessio Veronese, Silvio Lauricella, Calogero Bonazzina, Erica Siravegna, Giulia Truini, Mauro Bardelli, Alberto Siena, Salvatore ESMO Open Correspondence BMJ Publishing Group 2016-08-04 /pmc/articles/PMC5070243/ /pubmed/27843629 http://dx.doi.org/10.1136/esmoopen-2016-000079 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| spellingShingle | Correspondence Sartore-Bianchi, Andrea Valtorta, Emanuele Amatu, Alessio Veronese, Silvio Lauricella, Calogero Bonazzina, Erica Siravegna, Giulia Truini, Mauro Bardelli, Alberto Siena, Salvatore Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer |
| title | Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer |
| title_full | Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer |
| title_fullStr | Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer |
| title_full_unstemmed | Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer |
| title_short | Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer |
| title_sort | clonal evolution and kras-met coamplification during secondary resistance to egfr-targeted therapy in metastatic colorectal cancer |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070243/ https://www.ncbi.nlm.nih.gov/pubmed/27843629 http://dx.doi.org/10.1136/esmoopen-2016-000079 |
| work_keys_str_mv | AT sartorebianchiandrea clonalevolutionandkrasmetcoamplificationduringsecondaryresistancetoegfrtargetedtherapyinmetastaticcolorectalcancer AT valtortaemanuele clonalevolutionandkrasmetcoamplificationduringsecondaryresistancetoegfrtargetedtherapyinmetastaticcolorectalcancer AT amatualessio clonalevolutionandkrasmetcoamplificationduringsecondaryresistancetoegfrtargetedtherapyinmetastaticcolorectalcancer AT veronesesilvio clonalevolutionandkrasmetcoamplificationduringsecondaryresistancetoegfrtargetedtherapyinmetastaticcolorectalcancer AT lauricellacalogero clonalevolutionandkrasmetcoamplificationduringsecondaryresistancetoegfrtargetedtherapyinmetastaticcolorectalcancer AT bonazzinaerica clonalevolutionandkrasmetcoamplificationduringsecondaryresistancetoegfrtargetedtherapyinmetastaticcolorectalcancer AT siravegnagiulia clonalevolutionandkrasmetcoamplificationduringsecondaryresistancetoegfrtargetedtherapyinmetastaticcolorectalcancer AT truinimauro clonalevolutionandkrasmetcoamplificationduringsecondaryresistancetoegfrtargetedtherapyinmetastaticcolorectalcancer AT bardellialberto clonalevolutionandkrasmetcoamplificationduringsecondaryresistancetoegfrtargetedtherapyinmetastaticcolorectalcancer AT sienasalvatore clonalevolutionandkrasmetcoamplificationduringsecondaryresistancetoegfrtargetedtherapyinmetastaticcolorectalcancer |